The dark art of tax dodging
It shows how desperately we need corporate tax reform when “even a company like P&G practices the dark tax-avoiding arts,” said Allan Sloan at Fortune.
Allan Sloan
Fortune
It’s not just companies “associated with financial wheeling and dealing” that dodge taxes, said Allan Sloan. Procter & Gamble, owner of Tide detergent and Bounty paper towels, is behind some of the “most clever and innovative tax avoiding” around. P&G has paid no taxes on several major deals over the past decade by using a complex financial loophole similar to one Congress blocked in 1997.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
P&G’s transactions are “perfectly legal,” but they’re “so convoluted that you have to be a tax techie (or a masochist) to make your way through them.” By my estimates, the Cincinnati-based consumer giant has made $6 billion by unloading its Jif, Crisco, Folgers, and Pringles brands, all tax-free. Straight sales “would have triggered a $2 billion federal tax bill and a hefty state tax bill.”
It shows how desperately we need corporate tax reform when “even a company like P&G practices the dark tax-avoiding arts.” Lower tax rates alone won’t solve the problem. “Corporate tax avoidance is as American as apple pie,” and companies will pursue it until “all available loopholes get nailed shut.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'All too often, we get caught up in tunnel vision'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
2024: the year of legacy media failures
In the Spotlight From election criticism to continued layoffs, the media has had it tough in 2024
By Justin Klawans, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Issue of the week: Jamie Dimon’s big raise
feature After a year of lawsuits, fines, and government probes, JPMorgan is giving CEO Jamie Dimon a massive raise.
By The Week Staff Last updated
-
Issue of the week: Twitter’s public stock offering
feature As Twitter prepares for its initial public offering, “its books aren’t pretty.”
By The Week Staff Last updated
-
Issue of the week: JPMorgan in Washington’s crosshairs
feature The biggest U.S. bank is discussing an $11 billion payment to settle government investigations related to the mortgage crisis.
By The Week Staff Last updated
-
Breaking cable TV’s power
feature Why is cable television’s monopoly so stubborn?
By The Week Staff Last updated
-
Why I’ll never go to Davos
feature As long as leaders are unwilling to “give up control of their narratives,” collaboration on major global problems will remain impossible, said Mohamed El-Erian at Reuters.com.
By The Week Staff Last updated
-
Wal-Mart’s art of shame
feature Several paintings in the Crystal Bridges Museum of American Art strike me as “especially pointed commentaries” on the retailer’s baleful effect on our country and its economy, said Jeffrey Goldberg at Bloomberg.com.
By The Week Staff Last updated